Blaine Davis insider trades

Open-market stock purchases and sales by Blaine Davis, Chief Financial Officer at Cartesian Therapeutics, Inc, from SEC Form 4 filings since Feb 11, 2020.

Recent trades

DateStockTradeValue
Jan 6, 2026RNAC Cartesian Therapeutics, IncSold$72.2K
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—

Companies traded

  • RNAC Cartesian Therapeutics, Inc: 3 sales, last Jan 6, 2026
  • SELB Selecta Biosciences Inc: other filings, last Nov 28, 2022
  • TARA Protara Therapeutics, Inc: 1 buy, last Jul 15, 2022

Get free alerts when Blaine Davis files a new trade →